592 related articles for article (PubMed ID: 23248205)
1. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
[TBL] [Abstract][Full Text] [Related]
2. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction.
De Caterina R; Talmud PJ; Merlini PA; Foco L; Pastorino R; Altshuler D; Mauri F; Peyvandi F; Lina D; Kathiresan S; Bernardinelli L; Ardissino D;
Atherosclerosis; 2011 Feb; 214(2):397-403. PubMed ID: 21130994
[TBL] [Abstract][Full Text] [Related]
3. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
5. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
6. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
7. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
[TBL] [Abstract][Full Text] [Related]
8. Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
[TBL] [Abstract][Full Text] [Related]
9. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
Zhai G; Wen P; Guo L; Chen L
Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
[TBL] [Abstract][Full Text] [Related]
10. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
[TBL] [Abstract][Full Text] [Related]
12. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
13. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
[TBL] [Abstract][Full Text] [Related]
14. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
15. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
JAMA; 2009 Jun; 301(22):2331-9. PubMed ID: 19509380
[TBL] [Abstract][Full Text] [Related]
16. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
17. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
[TBL] [Abstract][Full Text] [Related]
18. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
Haase CL; Tybjærg-Hansen A; Qayyum AA; Schou J; Nordestgaard BG; Frikke-Schmidt R
J Clin Endocrinol Metab; 2012 Feb; 97(2):E248-56. PubMed ID: 22090275
[TBL] [Abstract][Full Text] [Related]
19. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels.
Li YY; Yin RX; Lai CQ; Li M; Long XJ; Li KL; Liu WY; Zhang L; Wu JZ
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):947-56. PubMed ID: 20708914
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
; Sarwar N; Sandhu MS; Ricketts SL; Butterworth AS; Di Angelantonio E; Boekholdt SM; Ouwehand W; Watkins H; Samani NJ; Saleheen D; Lawlor D; Reilly MP; Hingorani AD; Talmud PJ; Danesh J
Lancet; 2010 May; 375(9726):1634-9. PubMed ID: 20452521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
